KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Common Equity (2018 - 2025)

Historic Common Equity for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $15.9 million.

  • ClearPoint Neuro's Common Equity fell 4526.4% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 4526.4%. This contributed to the annual value of $25.4 million for FY2024, which is 1991.22% up from last year.
  • ClearPoint Neuro's Common Equity amounted to $15.9 million in Q3 2025, which was down 4526.4% from $19.7 million recorded in Q2 2025.
  • ClearPoint Neuro's Common Equity's 5-year high stood at $48.8 million during Q4 2021, with a 5-year trough of $15.9 million in Q3 2025.
  • Over the past 5 years, ClearPoint Neuro's median Common Equity value was $32.4 million (recorded in 2023), while the average stood at $32.7 million.
  • Per our database at Business Quant, ClearPoint Neuro's Common Equity skyrocketed by 348222.55% in 2021 and then plummeted by 4526.4% in 2025.
  • ClearPoint Neuro's Common Equity (Quarter) stood at $48.8 million in 2021, then fell by 24.39% to $36.9 million in 2022, then tumbled by 42.6% to $21.2 million in 2023, then rose by 19.91% to $25.4 million in 2024, then crashed by 37.48% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q3 2025, $19.7 million for Q2 2025, and $20.0 million during Q1 2025.